UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

UnitedHealth Group delivered a profit beat for the quarter, but not the kind that investors wanted to see. Heard on the ...

Medical costs continue to surge more than expected for health insurers.

UnitedHealth's stock was diving 3.7%, to pull back from a record high, and enough to pace the Dow's premarket losers, after ...

I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...

UnitedHealth Group stock fell more than 8% in early trading Tuesday as the Minnesota-based health care giant reported higher ...

Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...

UnitedHealth’s stock took a hit in early trading Tuesday, after the healthcare giant beat third-quarter profit and revenue ...

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. However, I rate it as a Buy. The company's long-term EPS growth target of 13-16% ...

UnitedHealth Group kicked off another round of earnings calls for major health insurance companies on Tuesday morning, where ...

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...

On Wednesday, KeyBanc made an adjustment to the stock price target for UnitedHealth Group (NYSE:UNH), reducing it from $675.00 to $650.00, while maintaining an Overweight rating on the stock.